| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +27,551 | 26% | $4.69 | +$129,141 |
| Sells | 4 | -77,647 | 74% | $4.76 | -$369,585 |
| Net | 0 | -50,096 | -48% | -$240,444 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| NOVARTIS PHARMA AG | 10%+ Owner | $4,590,753 | 15 Jun 2022 | ||
| DEREK JANTZ | Chief Scientific Officer, Director | $1,509,439 | 07 Jun 2022 | ||
| Michael Amoroso | President and CEO, Director | $750,081 | -$199,518 | -21% | 02 Nov 2025 |
| R. MATTHEW KANE | President and CEO, Director | $749,324 | 07 Jun 2021 | ||
| John Alexander Kelly | Chief Financial Officer | $501,664 | -$71,619 | -12% | 02 Nov 2025 |
| J. JEFFERSON SMITH | Chief Research Officer | $470,064 | -$50,031 | -9.6% | 02 Jun 2025 |
| Kevin Buehler | Director | $234,961 | +$42,239 | +22% | 25 Jun 2025 |
| Melinda Brown | Director | $233,941 | +$29,408 | +14% | 15 Dec 2025 |
| Geno Germano | Director | $230,639 | +$31,385 | +16% | 16 Dec 2025 |
| Stanley Frankel | Director | $209,458 | +$26,109 | +14% | 16 Dec 2025 |
| Shari Lisa Pire | Director | $189,875 | 27 May 2025 | ||
| Dario Scimeca | General Counsel and Secretary | $183,394 | -$48,416 | -21% | 02 Nov 2025 |
| Samuel C. Wadsworth | Director | $161,277 | 04 Jun 2024 | ||
| Alan List | Chief Medical Officer | $56,440 | 01 May 2024 | ||
| DAVID S. THOMSON | Chief Operating Officer | $41,260 | 23 Jun 2021 | ||
| Shane Barton | VP & Corporate Controller | $12,418 | 07 Jun 2023 | ||
| FAYAZ KHAZI | CEO of Elo Life Systems | $8,880 | 07 Jun 2021 | ||
| Shalini Sharp | Director | 10 May 2021 | |||
| Raymond F. Schinazi | Director | 10 May 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|